Canadian Smoking Cessation Clinical Practice Guideline
Canadian Smoking Cessation Clinical Practice Guideline
Canadian Smoking Cessation Clinical Practice Guideline
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
CANADIAN SMOKING CESSATION GUIDELINE• SPECIFIC POPULATIONS: Youth (Children and Adolescents) ................. 36OVERVIEW OF EVIDENCE ............................................................................. 36BACKGROUND ............................................................................................... 37CAN-ADAPTT SUMMARY STATEMENTS ........................................................ 38SUMMARY STATEMENT #1 .................................................................................... 38SUMMARY STATEMENT #2 .................................................................................... 38SUMMARY STATEMENT #3 .................................................................................... 38CLINICAL CONSIDERATIONS ........................................................................ 38TOOLS/RESOURCES ..................................................................................... 40RESEARCH GAPS .......................................................................................... 40• APPENDICES .......................................................................................... 41APPENDIX A – <strong>Guideline</strong> Development Process Flow Diagram ........................ 42APPENDIX B – Grade of Recommendation & Level of EvidenceSummary Table for CAN-ADAPTT Summary Statements .................................. 43APPENDIX C – <strong>Clinical</strong> <strong>Practice</strong> <strong>Guideline</strong>s Identified in November 2006 ......... 44APPENDIX D – <strong>Clinical</strong> <strong>Practice</strong> <strong>Guideline</strong>s Identified in December 2008 ......... 45APPENDIX E – <strong>Clinical</strong> <strong>Practice</strong> <strong>Guideline</strong>s Used as Evidence Base for<strong>Guideline</strong> Development ................................................................................... 46APPENDIX F – Strength of Evidence Classification Tables for <strong>Clinical</strong><strong>Practice</strong> <strong>Guideline</strong>s Used as Evidence Base for CAN-ADAPTT’s<strong>Guideline</strong> Development ................................................................................... 47APPENDIX G – List of Committees .................................................................. 49APPENDIX H – References ............................................................................. 50